Nektar Therapeutics Newsroom

Oppenheimer Maintains Nektar Therapeutics(NKTR.US) With Hold Rating

Moomoo NewsNov 12 08:31 ET

Oppenheimer Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)

TipRanksNov 12 07:52 ET

Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 4 07:35 ET

Nektar Therapeutics Analyst Ratings

BenzingaNov 4 06:54 ET

Piper Sandler Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $7

Moomoo NewsNov 4 06:32 ET

BTIG Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $4

Moomoo NewsSep 30 14:32 ET

Nektar Therapeutics Analyst Ratings

BenzingaSep 30 10:57 ET

Analysts Conflicted on These Healthcare Names: Nektar Therapeutics (NKTR) and BioNTech SE (BNTX)

TipRanksMay 24 06:05 ET

Nektar Therapeutics Analyst Ratings

BenzingaMar 6 09:47 ET

Jefferies Adjusts Nektar Therapeutics Price Target to $1 From $0.50, Maintains Hold Rating

MT NewswiresMar 5 12:50 ET

Nektar Therapeutics Analyst Ratings

BenzingaNov 20, 2023 08:28 ET

Nektar Therapeutics Analyst Ratings

BenzingaNov 9, 2023 09:17 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), Aligos Therapeutics (ALGS) and Nektar Therapeutics (NKTR)

TipRanksNov 8, 2023 01:22 ET

Mizuho Reiterates Neutral on Nektar Therapeutics, Maintains $6 Price Target

BenzingaAug 7, 2023 12:30 ET

Nektar Therapeutics Analyst Ratings

BenzingaAug 7, 2023 12:29 ET

Mizuho Securities Sticks to Their Hold Rating for Nektar Therapeutics (NKTR)

TipRanksAug 7, 2023 10:05 ET

SVB Securities Sticks to Its Hold Rating for Nektar Therapeutics (NKTR)

TipRanksMay 11, 2023 12:47 ET

Jefferies Upgrades Nektar Therapeutics (NKTR) to a Hold

TipRanksMay 10, 2023 04:37 ET

Mizuho Securities Sticks to Its Hold Rating for Nektar Therapeutics (NKTR)

TipRanksMay 9, 2023 23:17 ET

SVB Securities Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)

TipRanksMay 1, 2023 11:01 ET